428 related articles for article (PubMed ID: 32213018)
1. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
[TBL] [Abstract][Full Text] [Related]
2. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
3. The Role of Fecal
Liu K; Yang X; Zeng M; Yuan Y; Sun J; He P; Sun J; Xie Q; Chang X; Zhang S; Chen X; Cai L; Xie Y; Jiao X
Dis Markers; 2021; 2021():1171239. PubMed ID: 34853619
[TBL] [Abstract][Full Text] [Related]
4. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
Löwenmark T; Löfgren-Burström A; Zingmark C; Eklöf V; Dahlberg M; Wai SN; Larsson P; Ljuslinder I; Edin S; Palmqvist R
Sci Rep; 2020 Sep; 10(1):15250. PubMed ID: 32943695
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bacterial quantities in left and right colon biopsies and faeces.
Lyra A; Forssten S; Rolny P; Wettergren Y; Lahtinen SJ; Salli K; Cedgård L; Odin E; Gustavsson B; Ouwehand AC
World J Gastroenterol; 2012 Aug; 18(32):4404-11. PubMed ID: 22969206
[TBL] [Abstract][Full Text] [Related]
6. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
Xie YH; Gao QY; Cai GX; Sun XM; Sun XM; Zou TH; Chen HM; Yu SY; Qiu YW; Gu WQ; Chen XY; Cui Y; Sun D; Liu ZJ; Cai SJ; Xu J; Chen YX; Fang JY
EBioMedicine; 2017 Nov; 25():32-40. PubMed ID: 29033369
[TBL] [Abstract][Full Text] [Related]
7. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J
Gastroenterology; 2020 Sep; 159(3):969-983.e4. PubMed ID: 32387495
[TBL] [Abstract][Full Text] [Related]
8. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
[TBL] [Abstract][Full Text] [Related]
9. Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy.
Young C; Wood HM; Fuentes Balaguer A; Bottomley D; Gallop N; Wilkinson L; Benton SC; Brealey M; John C; Burtonwood C; Thompson KN; Yan Y; Barrett JH; Morris EJA; Huttenhower C; Quirke P
Clin Cancer Res; 2021 Apr; 27(8):2246-2254. PubMed ID: 33658300
[TBL] [Abstract][Full Text] [Related]
10. DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.
Baxter NT; Koumpouras CC; Rogers MA; Ruffin MT; Schloss PD
Microbiome; 2016 Nov; 4(1):59. PubMed ID: 27842559
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
Leung A; Tsoi H; Yu J
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
[TBL] [Abstract][Full Text] [Related]
12. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
13. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
[TBL] [Abstract][Full Text] [Related]
14. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.
Malagón M; Ramió-Pujol S; Serrano M; Serra-Pagès M; Amoedo J; Oliver L; Bahí A; Mas-de-Xaxars T; Torrealba L; Gilabert P; Miquel-Cusachs JO; García-Nimo L; Saló J; Guardiola J; Piñol V; Cubiella J; Castells A; Aldeguer X; Garcia-Gil J
Aliment Pharmacol Ther; 2019 Jun; 49(11):1410-1420. PubMed ID: 31025420
[TBL] [Abstract][Full Text] [Related]
15.
Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of faecal
Wong SH; Kwong TNY; Chow TC; Luk AKC; Dai RZW; Nakatsu G; Lam TYT; Zhang L; Wu JCY; Chan FKL; Ng SSM; Wong MCS; Ng SC; Wu WKK; Yu J; Sung JJY
Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940
[TBL] [Abstract][Full Text] [Related]
17. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
18.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the Abundance and Co-occurrence of
Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
[No Abstract] [Full Text] [Related]
20. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]